EcoDrugPlus

Integrin Alpha-5-Like

Ensembl ID : ENSNFUG00015013119
Gene Symbol: LOC107385841
3 Cross references
197 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSNFUG00015003702
Gene Symbol: ITGB3A
1 Cross references
201 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSNFUG00015013225
Gene Symbol: LOC107383442
3 Cross references
228 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSNFUG00015007585
Gene Symbol: LOC107387874
3 Cross references
194 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSNFUG00015012080
Gene Symbol: ITGA4
1 Cross references
225 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSNFUG00015019282
Gene Symbol: ITGB1
3 Cross references
214 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSNFUG00015020515
Gene Symbol: ITGB5
3 Cross references
207 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSNFUG00015003915
Gene Symbol: ITGB6
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSNFUG00015025236
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSNFUG00015007508
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSNFUG00015024700
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSNFUG00015025050
Gene Symbol: LOC107387279
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).